FEATURED CONTRIBUTED CONTENT

Why can’t we beat clinical depression?


Why can’t we beat clinical depression?

Clinical depression is one of the most prevalent diseases in the civilized world. The symptoms are often misunderstood. The sufferers often don’t seek help for 10 years or longer. Society attaches a negative stigma to the condition. It is often confused with temporarily feeling depressed. This TED-Ed video provides a good overview on depression and describes […]

December 17, 2015More Clinical »
Key lessons from luxury brands show that successful customer experiences come down to out-performing and out-behaving the competition


Key lessons from luxury brands show that successful customer experiences come down to out-performing and out-behaving the competition

In this episode, we’ll discuss what pharma can learn from brands outside the industry that are focusing on the customer experience. Brands such as The Ritz-Carlton, The Four Seasons, and Starbucks have successfully embraced the customer experience and, as a result, have earned loyalty and built long-term relationships with customers. According to research conducted by […]

December 17, 2015More Clinical »
Meet the Creepy, Crawly Future of Medicine


Meet the Creepy, Crawly Future of Medicine

Leeches, maggots, and scorpions are the stuff of scary stories and nightmares. They may also present some of the best opportunities for medical breakthroughs. Meet seven of the most promising creepy, crawly critters who could have a massive impact as we develop new medicines. Are these creatures the future of medicine? Leeches Scorpoins Maggots Silkworms Blister […]

December 14, 2015More Clinical »
Great Information on Rare Diseases and Orphan Drugs


Great Information on Rare Diseases and Orphan Drugs

If you work in the rare disease space, you will be very interested in this blog post. Publicis Touchpount Solutions recently published an outstanding white paper on rare diseases and orphan drugs. It’s packed with valuable statistics, research findings, images, and charts. Compared to most white papers, it’s a fairly deep dive, with 25 pages […]

February 8, 2016More Clinical »
10 Amazing Medical Nanotechnology Breakthroughs


10 Amazing Medical Nanotechnology Breakthroughs

We’ve been hearing about the promise of medical nanotechnology for decades. Many of those promises are becoming a reality. From better diagnostic tools to building artificial tissue to rooting out cancer, the applications of medical nanotechnology seem to have no bounds. This article provides an overview of 10 of the more promising developments in medical nanotechnology. […]

December 15, 2015More Clinical »
Providence Medical Technology Builds Clinical Database within a Week of Using ClinCapture


Providence Medical Technology Builds Clinical Database within a Week of Using ClinCapture

Providence Medical Technology chose ClinCapture® EDC platform for the ability to build studies themselves without prior training or programming experience, leveraging its intuitive drag-and-drop features offered in ClinCapture “Build Studio”. The medical device company reduced their clinical trial cost by using the ClinCapture Standard package, which is the only free, validated EDC offer available on […]

October 28, 2015More Clinical »
Insights into how marketing and sales can work together to deliver great experiences


Insights into how marketing and sales can work together to deliver great experiences

In this episode, we’ll explore the intricacies of transforming the industry’s traditional approach to sales and marketing to one that creates excellent customer experiences for patients and healthcare professionals (HCPs). Today, customers’ needs are changing, they have greater time constraints, and are consulting multiple sources for health information. These shifts necessitate that companies communicate with […]

December 17, 2015More Clinical »
Using Smarter Testing Strategies to Optimize Clinical Protocol Development


Using Smarter Testing Strategies to Optimize Clinical Protocol Development

This e-book explores how planning for clinical diagnostic testing with a central lab partner early in clinical protocol development can help optimize clinical trials, drive efficiencies, avoid potential protocol amendments, and minimize costly study delays.

December 23, 2015More Clinical »
Ten Ways to Derail a Clinical Trial


Ten Ways to Derail a Clinical Trial

There are many ways that your project can be delayed, and often these are managed in real time, rather than proactively on the front end, where they can be most effectively controlled, and minimize the impact to timelines and enrollment or even actual study conduct. If you don’t know where to start, this article offers 10 […]

December 23, 2015More Clinical »
The Digital Health Debate


The Digital Health Debate

This report is a summary of findings from Cello Health Insight’s 2015 research survey of doctors across eight markets; including the UK, France, Germany, Italy, Spain, the US, China and Brazil. The research explores the ways in which doctors are interacting with digital communication channels and digital devices in the workplace – focusing on how they are using these to exchange information and communicate […]

January 13, 2016More Clinical »
Patients Defend Afrezza


Patients Defend Afrezza

Written by: Robin Robinson, Senior Editor, PharmaVOICE Magazine On Friday, Jan. 8, 2016, PharmaVOICE featured a news story quoting a third party in its This Week’s News In Review regarding Sanofi’s decision to dissolve the marketing partnership for Afrezza with MannKind. Readers in support of MannKind reached out to us to show their support for […]

January 13, 2016More Clinical »
Orphan Drug Success: Engaging Key Stakeholders to Deliver Positive Outcomes


Orphan Drug Success: Engaging Key Stakeholders to Deliver Positive Outcomes

Taken together, rare diseases afflict as many as 30 million Americans, nearly 10% of the US population. To date, as many as 8,000 rare diseases have been identified, but only 5% of rare diseases currently have any FDA-approved drug treatment. The orphan drug marketplace continues to represent a significant opportunity for research-based biopharmaceutical firms. Many […]

January 27, 2016More Clinical »
Considerations in Demonstrating Value in the Oncology Clinical Setting


Considerations in Demonstrating Value in the Oncology Clinical Setting

Incorporating HEOR evidence into oncology drug development pathways is no longer optional, but essential. In this session we identify the reasons for increased importance of demonstrating value in clinical oncology, discuss the ways in which HEOR evidence is the best mechanism to address this challenge, and challenge those involved in oncology drug development to reconsider […]

January 26, 2016More Clinical »
Endpoint Based Protocol Development: An Outcomes Based Approach to Clinical Trial Testing


Endpoint Based Protocol Development: An Outcomes Based Approach to Clinical Trial Testing

In this interview, Mark Engelhart offers an alternative approach to clinical trial testing that involves consulting with a central lab in matching clinical diagnostic endpoints to outcomes. Mark will also talk about the evolving role that central labs are playing in optimizing clinical trials, driving efficiencies, avoiding potential protocol amendments, and minimizing costly study delays […]

December 23, 2015More Clinical »
Wearables and Health Apps: How Pharma Will Drive the Future of Disease Management


Wearables and Health Apps: How Pharma Will Drive the Future of Disease Management

In this podcast, Mr. Mannu talks about the adoption rate for physicians regarding wearables and health apps, the consumer movement toward personal health technologies, and how the life sciences industry can participate in its growth.

January 13, 2016More Clinical »
FEEDBACK